When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALPMY - Astellas' gilteritinib OK'd in Europe for type of AML
Astellas Pharma Inc. ADR
The European Commission approves Astellas Pharma's (OTCPK:ALPMY) XOSPATA (gilteritinib) for the treatment of adult patients with relapsed/refractory FLT3 mutation-positive acute myeloid leukemia (AML), a type of AML with a poor prognosis.
More news on: Astellas Pharma Inc., Astellas Pharma Inc., Healthcare stocks news,